Aetna Agrees to Pay $117.7 Million to Resolve False Claims Act Allegations
Aetna Inc., one of the largest health insurers in the United States, has agreed to pay $117.7 million to resolve allegations that it submitted false or inaccurate diagnosis codes for its Medicare Advantage plan members. The improper coding was intended to inflate Medicare payments by making enrollees appear sicker and thus more costly to cover.
This settlement follows claims brought under the False Claims Act, which seeks to protect government funds from fraudulent billing. Medicare Advantage plans, like those offered by Aetna, receive monthly payments adjusted by risk scores that reflect beneficiaries’ health conditions. By submitting inaccurate codes, Aetna allegedly overstated these risks, leading to higher payments from the Centers for Medicare & Medicaid Services (CMS).
The ramifications of this case impact both federal healthcare spending and taxpayer dollars, as Medicare funding is a critical public resource. Medicare beneficiaries enrolled in these private plans may also face indirect consequences, such as potential disruptions or increased premiums in future years stemming from such fraud.
This settlement sends a strong message about the government’s commitment to policing Medicare Advantage billing practices. It reinforces the need for insurers to accurately report health data, ensuring taxpayer money supports legitimate care costs rather than inflated reimbursements.
